THE DEFINITIVE GUIDE TO PMTA 0 11

In addition, it addresses the FDA’s communications While using the applicant, the retention of information that support the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant could transfer possession of the SE report back to a brand new applicant and electronic submission of the SE